Dr Martens PLC 22.7% potential upside indicated by RBC Capital Markets

Dr Martens PLC with ticker (LON:DOCS) now has a potential upside of 22.7% according to RBC Capital Markets.



RBC Capital Markets set a target price of 525 GBX for the company, which when compared to the Dr Martens PLC share price of 406 GBX at opening today (25/11/2021) indicates a potential upside of 22.7%. Trading has ranged between 356 (52 week low) and 522 (52 week high) with an average of 899,714 shares exchanging hands daily. The market capitalisation at the time of writing is £3,945,914,044.

Dr. Martens PLC, formerly Dr. Martens Limited, is a United Kingdom-based company that offers a footwear brand. The Company operates through three reporting segments: Europe, the MiddleEast and Africa (EMEA), Americas and Asia-Pacific (APAC). Its product categories include Originals, Fusion, Kids, Casual and Accessories. The Originals category comprises boots, shoes and loafers and also included within the Originals category is the Made in England range. The Fusion category comprises platform boots and shoes, sandals, heels and refined take downs of the Originals. Within the Kids category is the mini-me range, which includes certain Icons taken down to smaller sizes. It offers accessories, including shoe related products such as shoe care, laces and socks, leather bags and small leather items. It operates its own Dr. Martens e-commerce sites in the United Kingdom, the United States, Japan, South Korea and Continental Europe, including France, Germany, Italy, Spain and the Netherlands.